The Benefit of Post-Mastectomy Radiotherapy in ypN0 Patients after Neoadjuvant Chemotherapy According to Molecular Subtypes.
Won Kyung ChoWon ParkDoo Ho ChoiYong Bae KimJin Ho KimSu Ssan KimKyubo KimJin Hee KimSung Ja AhnSun-Young LeeJeongshim LeeSang-Won KimJeanny KwonKi Jung AhnPublished in: Journal of breast cancer (2019)
In patients who achieve ypN0 following NAC and mastectomy, PMRT shows no additional survival benefits for any molecular subtype.